Immucell Corp /De/ (ICCC) — 10-Q Filings
All 10-Q filings from Immucell Corp /De/. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
ImmuCell Swings to Profit on Strong Sales, Margin Expansion
— Aug 14, 2025 Risk: medium
ImmuCell Corporation reported a significant turnaround, achieving net income of $1,948,863 for the six-month period ended June 30, 2025, a substantial improveme -
ImmuCell Corp Files Q1 2025 10-Q
— May 14, 2025 Risk: low
ImmuCell Corporation filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in Delaware and headquartered in Portland, Maine, r -
ImmuCell Corp Files Q3 2024 10-Q
— Nov 13, 2024 Risk: medium
ImmuCell Corporation filed its 10-Q for the quarterly period ended September 30, 2024. The company, incorporated in Delaware, reported its financial status and -
ImmuCell Corp Files Q2 2024 10-Q Report
— Aug 13, 2024 Risk: medium
ImmuCell Corporation filed its 10-Q for the quarterly period ended June 30, 2024. The company, incorporated in Delaware and headquartered in Portland, Maine, re -
ImmuCell Corporation Files Quarterly Report (10-Q) for Period Ended March 31, 2024
— May 14, 2024 Risk: low
IMMUCELL CORP /DE/ (ICCC) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. ImmuCell Corporation filed a 10-Q report for the quarterly period ended
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX